BC
Bradley L Campbell
President and CEO

Bradley L Campbell insider trades: Amicus Therapeutics (FOLD) stock buys and sales

President and CEO, Amicus Therapeutics Last trade Mar 2, 2026 132 Form 4 filings
$2.5M
Sold, last 12 months
5 sales
$0
Bought, last 12 months
0 buys
87
Open-market trades
since 2014
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Bradley reports to the SEC

Open-market buys and sales

87 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 2, 2026FOLD↓ Sell$323K
Jan 20, 2026FOLD↓ Sell$1.1M
Dec 15, 2025FOLD↓ Sell$846K
Dec 1, 2025FOLD↓ Sell$146K
Nov 24, 2025FOLD↓ Sell$147K
Feb 19, 2025FOLD↓ Sell$4K
Dec 2, 2024FOLD↓ Sell$75K
Nov 6, 2024FOLD↓ Sell$99K
Nov 1, 2024FOLD↓ Sell$86K
Oct 1, 2024FOLD↓ Sell$79K
Sep 3, 2024FOLD↓ Sell$88K
Aug 1, 2024FOLD↓ Sell$78K
Jul 5, 2024FOLD↓ Sell$61K
Jul 1, 2024FOLD↓ Sell$14K
Jun 3, 2024FOLD↓ Sell$75K
May 1, 2024FOLD↓ Sell$76K
Apr 1, 2024FOLD↓ Sell$87K
Mar 1, 2024FOLD↓ Sell$208K
Feb 15, 2024FOLD↓ Sell$58K
Feb 1, 2024FOLD↓ Sell$199K
Jan 2, 2024FOLD↓ Sell$225K
Dec 1, 2023FOLD↓ Sell$130K
Nov 1, 2023FOLD↓ Sell$128K
Oct 2, 2023FOLD↓ Sell$131K
Sep 1, 2023FOLD↓ Sell$235K
Aug 1, 2023FOLD↓ Sell$268K
Jul 13, 2023FOLD↓ Sell$104K
Jul 3, 2023FOLD↓ Sell$144K
Jun 6, 2023FOLD↓ Sell$104K
Jun 1, 2023FOLD↓ Sell$133K
May 1, 2023FOLD↓ Sell$138K
Apr 3, 2023FOLD↓ Sell$131K
Mar 1, 2023FOLD↓ Sell$265K
Feb 1, 2023FOLD↓ Sell$260K
Jan 9, 2023FOLD↓ Sell$134K
Dec 1, 2022FOLD↓ Sell$67K
Nov 1, 2022FOLD↓ Sell$55K
Oct 3, 2022FOLD↓ Sell$58K
Sep 1, 2022FOLD↓ Sell$62K
Aug 1, 2022FOLD↓ Sell$55K
Jul 1, 2022FOLD↓ Sell$59K
Jun 21, 2022FOLD↓ Sell$164K
Mar 18, 2022FOLD↓ Sell$109K
Jan 3, 2022FOLD↓ Sell$65K
Dec 22, 2021FOLD↓ Sell$35K
Dec 1, 2021FOLD↓ Sell$116K
Nov 1, 2021FOLD↓ Sell$119K
Oct 1, 2021FOLD↓ Sell$105K
Sep 1, 2021FOLD↓ Sell$121K
Aug 5, 2021FOLD↓ Sell$211K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other FOLD insiders

Open-market trades in the last 12 months

About Bradley L Campbell's insider trades

Bradley L Campbell is President and CEO at Amicus Therapeutics (FOLD). Since Aug 20, 2014, Bradley has reported 3 open-market purchases worth $201K and 84 sales worth $14.0M on SEC Form 4. In the last 12 months: 5 sales ($2.5M).

Their filings also include option exercises (82 filings), grants and awards (40 filings), shares withheld for taxes (28 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FOLD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.